Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Chennamsetty, I; Kostner, KM; Claudel, T; Vinod, M; Frank, S; Weiss, TS; Trauner, M; Kostner, GM.
Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice.
J Lipid Res. 2012; 53(11):2405-2412 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Chennamsetty Indumathi
Claudel Thierry
Frank Saša
Kostner Gerhard
Trauner Michael
Vinod Manjula
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 7
| | | | | | |
Abstract:
Elevated plasma lipoprotein(a) (LPA) levels are recognized as an independent risk factor for cardiovascular diseases. Our knowledge on LPA metabolism is incomplete, which makes it difficult to develop LPA-lowering medications. Nicotinic acid (NA) is the main drug recommended for the treatment of patients with increased plasma LPA concentrations. The mechanism of NA in lowering LPA is virtually unknown. To study this mechanism, we treated transgenic (tg) APOA mice with NA and measured plasma APOA and hepatic mRNA levels. In addition, mouse and human primary hepatocytes were incubated with NA, and the expression of APOA was followed. Feeding 1% NA reduced plasma APOA and hepatic expression of APOA in tg-APOA mice. Experiments with cultured human and mouse primary hepatocytes in addition to reporter assays performed in HepG2 cells revealed that NA suppresses APOA transcription. The region between -1446 and -857 of the human APOA promoter harboring several cAMP response element binding sites conferred the negative effect of NA. In accordance, cAMP stimulated APOA transcription, and NA reduced hepatic cAMP levels. It is suggested that cAMP signaling might be involved in reducing APOA transcription, which leads to the lowering of plasma LPA.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Apolipoproteins A - genetics Apolipoproteins A - metabolism
Atherosclerosis - genetics Atherosclerosis - metabolism
Cells, Cultured -
Cyclic AMP - pharmacology
Gene Expression - drug effects
Hep G2 Cells -
Hepatocytes - drug effects Hepatocytes - metabolism
Humans -
Liver - drug effects Liver - metabolism
Mice -
Mice, Transgenic -
Niacin - pharmacology
RNA, Messenger -

Find related publications in this database (Keywords)
primary human hepatocytes
reporter assay
apolipoprotein(a)
mRNA expression
atherosclerosis
© Meduni Graz Impressum